Curis is a drug development company that is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. In expanding its drug development efforts in the field of cancer through its proprietary targeted cancer programs, Curis is building upon its previous experiences in targeting signaling pathways for the development of next generation targeted cancer therapies.
Lexington, US
Size (employees)
44 (est)
Curis was founded in 2000 and is headquartered in Lexington, US

Curis Office Locations

Curis has an office in Lexington
Lexington, US (HQ)
4 Maguire Rd

Curis Metrics

Curis Financial Metrics

Revenue (2016)

$7.5 m

Revenue growth (2015-16), %


Net income (2016)

($60.4 m)

Market capitalization (28-Apr-2017)

$343.4 m

Closing share price (28-Apr-2017)


Cash (31-Dec-2016)

$26 m
Curis's current market capitalization is $343.4 m.
Curis's revenue was reported to be $7.5 m in 2016
FY, 2013FY, 2014FY, 2015Y, 2016


$15 m$9.8 m$7.9 m$7.5 m

Revenue growth, %


Operating expense total

$24.4 m$25.7 m$64.4 m$65.6 m


($9.4 m)($15.9 m)($56.5 m)($58 m)

EBIT margin, %


Interest expense

$3.8 m$3.7 m$3.3 m$2.8 m

Interest income

$164.7 k$165.1 k$277.3 k$406 k

Net Income

($12.3 m)($18.7 m)($59 m)($60.4 m)
FY, 2013FY, 2014FY, 2015FY, 2016


$9.6 m$7.7 m$33.1 m$26 m

Accounts Receivable

$1.5 m$2 m$2.1 m$2.5 m


$495.3 k$489.8 k$1.2 m$1.3 m

Current Assets

$60.2 m$52.2 m$85.5 m$48.2 m


$445.7 k$407.7 k$277.7 k$413 k


$9 m$9 m$9 m$9 m

Total Assets

$80.6 m$62.6 m$95 m$57.8 m

Accounts Payable

$2 m$2.3 m$4.2 m$5.9 m

Current Liabilities

$6.6 m$10.1 m$10.8 m$13.5 m

Additional Paid-in Capital

$806.7 m$810 m$903.2 m$928.3 m

Retained Earnings

($760.8 m)($779.6 m)($838.5 m)($898.9 m)

Total Equity

$45.2 m$29.8 m$64.5 m$29.3 m

Financial Leverage

1.8 x2.1 x1.5 x2 x
FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

($12.3 m)($18.7 m)($59 m)($60.4 m)

Depreciation and Amortization

$141.5 k$155.1 k$160.8 k$193 k

Accounts Receivable

($569.1 k)($483.8 k)($145 k)($353 k)


Accounts Payable

Cash From Operating Activities

($9.5 m)($16.8 m)($29.9 m)($35.8 m)

Cash From Investing Activities

($13.6 m)$16.3 m($6.4 m)$30.1 m

Cash From Financing Activities

$20 m($1.3 m)$61.7 m($1.4 m)

Interest Paid

$2.9 m$4.4 m$3.3 m$2.8 m

Curis Market Value History

Curis Company Life

You may also be interested in